-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Special Interest Session on Sickle Cell Disease Centers: Ensuring Appropriate Care Across the Patient Lifespan

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Workforce, Hemoglobinopathies, Diversity, Equity, and Inclusion (DEI) , Diseases
Saturday, December 10, 2022: 4:00 PM-5:30 PM
La Nouvelle Orleans Ballroom AB (Ernest N. Morial Convention Center)
Chair:
Sophie M. Lanzkron, MD, Johns Hopkins School of Medicine
Disclosures:
Lanzkron: bluebird bio: Other: Adjudication committee, Research Funding; Novo Nordisk: Other: Adjudication committee; Pfizer: Consultancy, Current equity holder in publicly-traded company; Novartis: Consultancy, Research Funding; Glycomimetics: Consultancy; Imara: Research Funding; GBT: Research Funding; Novartis: Research Funding; Takeda: Research Funding; CSL-behring: Research Funding; HRSA: Research Funding; PCORI: Research Funding; Teva: Current equity holder in publicly-traded company.
Challenges and Opportunities in Developing a Sickle Cell Program for Adults at Upenn

Farzana Sayani, MD

Hospital of The University of Pennsylvania, Perelman School of Medicine , University of Pennsylvania, Philadelphia, PA
Consensus Recommendations on Health Maintenance for Adults with SCD

Sana Saif Ur Rehman, MD

Division of Hematology, Washington University School of Medicine, Saint Louis, MO
Elements Needed for Comprehensive Pediatric Care

Monica L. Hulbert, MD

Division of Hematology/ Oncology, Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>